ヨーロッパの多血小板血漿(PRP)市場

◆英語タイトル:Platelet Rich Plasma (PRP) Market: Europe Industry Analysis and Opportunity Assessment, 2016 - 2024
◆商品コード:FMI609178
◆発行会社(調査会社):Future Market Insights
◆発行日:2016年6月15日
◆ページ数:99
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ヨーロッパ
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD3,500 ⇒換算¥399,000見積依頼/購入/質問フォーム
EnterpriseUSD7,000 ⇒換算¥798,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。



【レポートの概要】

Future Market Insights offers 8-year forecast on the Europe PRP market between 2016 and 2024. In terms of value, the PRP market is expected to register a CAGR of 6.6% during the forecast period. This study demonstrates market dynamics and trends in EU5 and rest of European countries that are expected to influence the current environment and future status of the Europe PRP market over the forecast period.
Report Description

This Future Market Insights report examines the PRP market for the period 2016–2024. The primary objective of the report is to offer insights into developments in the PRP market that are significantly helping transform the healthcare industry into a more comprehensive industry.

The Europe PRP market report begins by defining ‘PRP’ and its types. It also lists the various application for PRP therapy. This is followed by an overview of the Europe PRP market. The overview section includes FMI’s analysis of the key trends, drivers, restraints, trends and opportunities that are influencing growth of PRP market currently. Impact analysis of the key growth drivers and restraints based on the weighted average model has also been included in the ‘European Platelet Rich Plasma (PRP) Market’ to better equip customers and readers with country specific trends and insights.

The primary driving factors for the PRP market are significant increase in the number of sports injuries, rising prevalence of musculoskeletal injuries, progressive demographic ageing of the older population and technological advancements in PRP therapy to improve success and recovery rate. Furthermore, increase in demand of PRP therapy in sports injuries and ease in regulatory approvals has also triggered growth of the Europe PRP market.

On the basis of product type, the Europe PRP market is segmented into instruments and kits product type segment. Furthermore, kits product type segment is further sub-segmented into P-PRP kits, L-PRP kits, L-PRF kits and P-PRF kits based on end product type and into autologous – PRP kits, homologous – PRP kits, and allogeneic – PRP kits based on the source of blood. Secondly, the market is also segmented based on application in orthopaedic industry. A detailed analysis of all the categories of application has been provided in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

The next section of the report highlights the PRP market by country. It provides the market outlook for 2016–2024 and sets the forecast within the context of the PRP market. The study discusses the key regional trends and contracts contributing to growth of the PRP market in European region, as well as analyses the extent to which the drivers are influencing this market in this region. Key country assessed in this report include the U.K., Germany, France, Italy, Spain and rest of Europe.

The above sections – by product type, application, and country – evaluate the present scenario and growth prospects of the PRP market for the period 2016–2024. We have considered 2015 as the base year and provided data for the forecast period, i.e. 2016–2024.

The forecast presented here assesses the total revenue generated across the PRP market in Europe region over the forecast period. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the PRP market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome on the basis of three different types of analysis, i.e. by supply side, downstream industry demand and the economic envelope.

It is imperative to note that in an ever-fluctuating European economy, we not only conduct forecasts in terms of CAGR, but also analyse based on key parameters, such as Year-on-Year (Y-o-Y) growth rates, to understand the predictability of the market and to identify the right opportunities in it.

The PRP market segments in terms of products, application and countries are analysed on the basis of their respective Basis Point (BPS) to understand the individual segment’s relative contribution to market growth. This detailed level of information is important for the identification of various key trends in the PRP market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the PRP market.

To understand key growth segments, Future Market Insights developed the PRP market ‘Attractiveness Index’. The resulting index helps providers to identify real market opportunities.

In the final section of the report on the PRP market, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, to access the key differentiators among the competitor firms. Key categories of providers covered in the report are instruments and kits. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the PRP value chain and the potential players with regard to the same. However, this section also includes market strategies and SWOT analysis of the main players in the market.

Detailed profiles of the medical device companies are also included in the scope of the report to evaluate their long-term and short-term strategies. Key players in the market include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd, Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., and Regen Lab S.A.

Key Segments Covered

Product Type
Instruments
Kits
Kits BY Type
Pure Platelet-Rich Plasma (P-PRP)
Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
Leukocyte-Platelet-Rich Fibrin (L-PRF)
Pure Platelet-Rich Fibrin (P-PRF)
Kits BY Origin
Autologous Platelet-Rich Plasma
Homologus Platelet-Rich Plasma
Allogeneic Platelet-Rich Plasma
By Application
Knee
Elbow
Foot and Ankle
Shoulder
CMF
Others

Key Countries Covered

Europe
The U.K.
France
Germany
Spain
Italy
Rest of Europe

Key Companies

Arthrex, Inc.
Stryker Corporation
Johnson and Johnsons Ltd
Zimmer Biomet Holdings Inc.
Terumo Corporation
Glofinn Oy
Medira Ltd.
Regen Lab S.A.

【レポートの目次】

Table Of Content

1.Research Methodology

2.Assumptions & Acronyms Used

3.Executive Summary

4.Platelet Rich Plasma Market overview

4.1.Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%)

4.2.Principle Growth Factors in PRP

5.Europe Platelet Rich Plasma Market Definitions

6.Platelet Rich Plasma Market : PEST Analysis and Key Regulations

7.Europe Platelet-rich Plasma Market Dynamics

7.1.Drivers

7.2.Restraints

7.3.Opportunities

7.4.Trends

8.Europe Platelet-rich Plasma (PRP) Market Revenue, by Product Type, 2013–2024

8.1.Introduction

8.1.1. Europe PRP Market Value Share & BPS Analysis, by Product Type, 2014 & 2024

8.1.2. Europe PRP Market Y-o-Y Growth Comparison, by Product Type, 2013–2024

8.2.Market Value Forecast, By Product Type

8.2.1. Instruments

8.2.1.1.Y-o-Y Growth Comparison

8.2.1.2.Market Value Forecast

8.2.2. Kits

8.2.2.1.Y-o-Y Growth Comparison

8.2.2.2.Market Value Forecast

8.2.2.3.Pure-Platelet Rich Plasma (P-PRP) Kits Sub-segment

8.2.2.3.1.Y-o-Y Growth Comparison

8.2.2.3.2.Market Value Forecast

8.2.2.4.Leukocyte-rich Platelet-rich Plasma (L-PRP) Kits Sub-segment

8.2.2.4.1.Y-o-Y Growth Comparison

8.2.2.4.2.Market Value Forecast

8.2.2.5.Leukocyte-Platelet-rich Fibrin (L-PRF) Kits Sub-segment

8.2.2.5.1.Y-o-Y Growth Comparison

8.2.2.5.2.Market Value Forecast

8.2.2.6.Pure- Platelet-rich Fibrin (P-PRF) Kits Sub-segment

8.2.2.6.1.Y-o-Y Growth Comparison

8.2.2.6.2.Market Value Forecast

8.2.2.7.Autologous Platelet-rich Plasma Kits Sub-segment

8.2.2.7.1.Y-o-Y Growth Comparison

8.2.2.7.2.Market Value Forecast

8.2.2.8.Homologous Platelet-rich Plasma Kits Sub-segment

8.2.2.8.1.Y-o-Y Growth Comparison

8.2.2.8.2.Market Value Forecast

8.2.2.9.Allogeneic Platelet-rich Plasma Kits Sub-segment

8.2.2.9.1.Y-o-Y Growth Comparison

8.2.2.9.2.Market Value Forecast

8.2.3.Europe PRP Market Attractiveness Analysis, by Product Type, 2014–2024

8.3.Europe Platelet-rich Plasma (PRP) Market Revenue, by Application, 2013–2024

8.3.1. Introduction

8.3.1.1.Europe PRP Market Value Share & BPS Analysis, by Application, 2014 & 2024

8.3.1.2.Europe PRP Market Y-o-Y Growth Comparison, by Application, 2013–2024

8.4.Market Value Forecast, By Application

8.4.1. Knee

8.4.1.1.Y-o-Y Growth Comparison

8.4.1.2.Market Value Forecast

8.4.2. Elbow

8.4.2.1.Y-o-Y Growth Comparison

8.4.2.2.Market Value Forecast

8.4.3. Foot and Ankle

8.4.3.1.Y-o-Y Growth Comparison

8.4.3.2.Market Value Forecast

8.4.4. Shoulder

8.4.4.1.Y-o-Y Growth Comparison

8.4.4.2.Market Value Forecast

8.4.5. CMF

8.4.5.1.Y-o-Y Growth Comparison

8.4.5.2.Market Value Forecast

8.4.6. Other

8.4.6.1.Y-o-Y Growth Comparison

8.4.6.2.Market Value Forecast

8.4.7.Europe PRP Market Attractiveness Analysis, by Application, 2014–2024

8.5.Europe Platelet-rich Plasma (PRP) Market Revenue, by Country, 2013–2024

8.5.1. Introduction

8.5.1.1.Europe PRP Market Value Share & BPS Analysis, by Country, 2014 & 2024

8.5.1.2.Europe PRP Market Y-o-Y Growth Comparison, by Country, 2013–2024

8.6.Market Value Forecast, By Country

8.6.1. Germany

8.6.1.1.Y-o-Y Growth Comparison

8.6.1.2.Market Value Forecast

8.6.2. France

8.6.2.1.Y-o-Y Growth Comparison

8.4.3.2.Market Value Forecast

8.6.3. U.K.

8.6.3.1.Y-o-Y Growth Comparison

8.6.3.2.Market Value Forecast

8.6.4. Italy

8.6.4.1.Y-o-Y Growth Comparison

8.6.4.2.Market Value Forecast

8.6.5. Spain

8.6.5.1.Y-o-Y Growth Comparison

8.6.5.2.Market Value Forecast

8.6.6. Rest of Europe

8.6.6.1.Y-o-Y Growth Comparison

8.6.6.2.Market Value Forecast

8.7.Europe PRP Market Attractiveness Analysis, by Country, 2014–2024

9.Competitive Landscape

9.1.Competition Dashboard

9.2.Company Profiles

9.2.1.Arthrex, Inc.

9.2.2.Stryker Corporation

9.2.3.Johnson and Johnsons Ltd

9.2.4.Zimmer Biomet Holdings Inc.

9.2.5. Terumo Corporation

9.2.6. Glofinn Oy

9.2.7. Medira Ltd.

9.2.8.Regen Lab S.A.



【レポートのキーワード】

多血小板血漿(PRP)

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[ヨーロッパの多血小板血漿(PRP)市場]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月10日現在 219,328 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆